Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jorge Aparicio

Showing results (81-90 of 93) with videos related to

Pageof 10
Sort By:
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|April 5, 2024
Hypertension as predictive factor for bevacizumab-containing first-line therapy in metastatic breast and colorectal cancer in BRECOL (GEICAM/2011-04) studyÁlvaro Rodríguez-Lescure, Javier Gallego, Pilar Garcia-Alfonso, et al.
European Journal of Cancer (Oxford, England : 1990)|May 4, 2020
Human chorionic gonadotropin-positive seminoma patients: A registry compiled by the global germ cell tumor collaborative group (G3)Christoph Seidel, Gedske Daugaard, Tim Nestler, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|April 20, 2024
Sequential RAS mutations evaluation in cell-free DNA of patients with tissue RAS wild-type metastatic colorectal cancer: the PERSEIDA (Cohort 2) studyManuel Valladares-Ayerbes, Maria José Safont, Encarnación González Flores, et al.
Oncotarget|March 10, 2015
ColoLipidGene: signature of lipid metabolism-related genes to predict prognosis in stage-II colon cancer patientsTeodoro Vargas, Juan Moreno-Rubio, Jesús Herranz, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|November 25, 2025
Correction: Hypertension as predictive factor for bevacizumab-containing first-line therapy in metastatic breast and colorectal cancer in BRECOL (GEICAM/2011-04) studyÁlvaro Rodríguez-Lescure, Javier Gallego, Pilar Garcia-Alfonso, et al.
Cancer Medicine|June 19, 2026
Studying When to Add Biological Therapy to Cytotoxic Therapy in Advanced Cancer Care Using Real World Data: How to Avoid Design Choices That Generate Immortal TimeXabier Garcia-Albeniz, Julia Vila-Guilera, Manuel Zamparini, et al.
JCO Precision Oncology|February 1, 2022
Clinical Impact of Circulating Tumor RAS and BRAF Mutation Dynamics in Patients With Metastatic Colorectal Cancer Treated With First-Line Chemotherapy Plus Anti-Epidermal Growth Factor Receptor TherapyJoan Maurel, Vicente Alonso, Pilar Escudero, et al.
Cancers|December 23, 2022
Evolution of <i>RAS</i> Mutations in Cell-Free DNA of Patients with Tissue <i>RAS</i> Wild-Type Metastatic Colorectal Cancer Receiving First-Line Treatment: The PERSEIDA StudyManuel Valladares-Ayerbes, Pilar Garcia-Alfonso, Jorge Muñoz Luengo, et al.
Journal of the National Cancer Institute|January 27, 2017
Prognostic Significance of Venous Thromboembolic Events in Disseminated Germ Cell Cancer PatientsEnrique Gonzalez-Billalabeitia, Daniel Castellano, Nora Sobrevilla, et al.
Future Oncology (London, England)|February 16, 2021
Real-life use of ramucirumab in gastric cancer in Spain: the RAMIS studyFederico Longo, Mónica Jorge, Ricardo Yaya, et al.
Pageof 10

Showing results (81-90 of 93) with videos related to

Sort By:
Pageof 10
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|April 5, 2024
Hypertension as predictive factor for bevacizumab-containing first-line therapy in metastatic breast and colorectal cancer in BRECOL (GEICAM/2011-04) studyÁlvaro Rodríguez-Lescure, Javier Gallego, Pilar Garcia-Alfonso, et al.
European Journal of Cancer (Oxford, England : 1990)|May 4, 2020
Human chorionic gonadotropin-positive seminoma patients: A registry compiled by the global germ cell tumor collaborative group (G3)Christoph Seidel, Gedske Daugaard, Tim Nestler, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|April 20, 2024
Sequential RAS mutations evaluation in cell-free DNA of patients with tissue RAS wild-type metastatic colorectal cancer: the PERSEIDA (Cohort 2) studyManuel Valladares-Ayerbes, Maria José Safont, Encarnación González Flores, et al.
Oncotarget|March 10, 2015
ColoLipidGene: signature of lipid metabolism-related genes to predict prognosis in stage-II colon cancer patientsTeodoro Vargas, Juan Moreno-Rubio, Jesús Herranz, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|November 25, 2025
Correction: Hypertension as predictive factor for bevacizumab-containing first-line therapy in metastatic breast and colorectal cancer in BRECOL (GEICAM/2011-04) studyÁlvaro Rodríguez-Lescure, Javier Gallego, Pilar Garcia-Alfonso, et al.
Cancer Medicine|June 19, 2026
Studying When to Add Biological Therapy to Cytotoxic Therapy in Advanced Cancer Care Using Real World Data: How to Avoid Design Choices That Generate Immortal TimeXabier Garcia-Albeniz, Julia Vila-Guilera, Manuel Zamparini, et al.
JCO Precision Oncology|February 1, 2022
Clinical Impact of Circulating Tumor RAS and BRAF Mutation Dynamics in Patients With Metastatic Colorectal Cancer Treated With First-Line Chemotherapy Plus Anti-Epidermal Growth Factor Receptor TherapyJoan Maurel, Vicente Alonso, Pilar Escudero, et al.
Cancers|December 23, 2022
Evolution of <i>RAS</i> Mutations in Cell-Free DNA of Patients with Tissue <i>RAS</i> Wild-Type Metastatic Colorectal Cancer Receiving First-Line Treatment: The PERSEIDA StudyManuel Valladares-Ayerbes, Pilar Garcia-Alfonso, Jorge Muñoz Luengo, et al.
Journal of the National Cancer Institute|January 27, 2017
Prognostic Significance of Venous Thromboembolic Events in Disseminated Germ Cell Cancer PatientsEnrique Gonzalez-Billalabeitia, Daniel Castellano, Nora Sobrevilla, et al.
Future Oncology (London, England)|February 16, 2021
Real-life use of ramucirumab in gastric cancer in Spain: the RAMIS studyFederico Longo, Mónica Jorge, Ricardo Yaya, et al.
Pageof 10